Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-897-5 | CAS number: 95193-83-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Remarks:
- Study of biliary excretion in isolated perfused liver
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Studies on the Fate of Quinoline Yellow in the Rat
- Author:
- Wahlstrom B., Blennow G. and Krantz C.
- Year:
- 1 979
- Bibliographic source:
- Food and Cosmetics Toxicology, 17, pp 1-3
Materials and methods
- Objective of study:
- metabolism
- other: Biliary excretion
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- - Principle of test: rats’ isolated liver was perfused with the test item added to the perfusion fluid. Biliary excretion was studied.
- Short description of test conditions: Animals used for studying biliary excretion in the isolated perfused liver were anaesthetized. The common bile duct was cannulated and the liver was dissected and connected to an artificial sys tem containing human erythrocytes and bovine albumin in a physiological salt solution. The volume of the perfusion fluid was 75 ml, the temperature was 37°C and the pH was 7.4. The test item was added to the perfusion fluid dissolved in 0.9% NaCI. Bile and perfusion fluid were sampled at regular intervals during the experiment. The perfusion usually lasted 3 hours.
- Parameters analysed/observed: Concentration of the test item in the perfusion fluid and in the bile and bile flow at different time’s interval. - GLP compliance:
- no
Test material
- Reference substance name:
- 1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts
- EC Number:
- 305-897-5
- EC Name:
- 1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts
- Cas Number:
- 95193-83-2
- Molecular formula:
- C18H11NO5S to C18H8NO11S3.3Na
- IUPAC Name:
- trisodium hydrogen bis(2-(1,3-dioxo-5-sulfonato-2,3-dihydro-1H-inden-2-yl)quinoline-8-sulfonate)
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Rats were SPF-bred.
- Weight at study initiation: 200 – 300 grams.
- Housing: Rats were maintained in special animal unit with strict hygienic barriers before the experiments.
- During the experiment the animals were anaesthetized with diethyl ether.
Administration / exposure
- Route of administration:
- other: Perfusion of isolated liver
- Vehicle:
- other: The test item was dissolved in 0.9% NaCl and added to the perfusion fluid (10-12% human erythroctìytes and 2.5% bovine albumin in a physiological salt solution.
- Details on exposure:
- The test item was dissolved in 0.9% NaCl solution and added to the perfusion fluid (10-12x human erythrocytes and 25% bovine albumin in a physiological salt solution).
Concentration of the test item in the perfusion fluid: 25 mg/100 mL
Volume of the perfusion fluid: 75 ml
Temperature of the perfusion fluid: 37°C
pH of the perfusion fluid: 7.4. - Duration and frequency of treatment / exposure:
- The perfusion usually lasted 3 hours.
Doses / concentrations
- Dose / conc.:
- 25 other: mg/100 mL of perfusion fluid
- No. of animals per sex per dose / concentration:
- 6 animals in total were used. The numebr of females and males was not specified.
- Control animals:
- not specified
- Positive control reference chemical:
- Not specified.
- Details on dosing and sampling:
- - Body fluid sampled: bile
- Time and frequency of sampling: the bile and the perfusion fluid were sampled several times during the 3 hours perfusion duration.
- Method type for identification: the test item in the bile was determined after extraction with 0.1 M HCI at 418 nm on a Beckman DB-25 spectrophotometer. The spectra of the test item extracted from bile were checked against those of test item standard solutions in 0.1 M HCI. - Statistics:
- Values are presented as means ± SEM.
Results and discussion
Main ADME resultsopen allclose all
- Type:
- excretion
- Results:
- About 70% of the administered dose was excreted into the bile within 3 hours. The maximum concentration of the test item in the bile, 30-50 mg/mL, was found after about 30 minutes.
- Type:
- metabolism
- Results:
- The recovery of the test item from perfusion fluid and bile was almost quantitative (about 95%), showing that the test item was not significantly metabolized.
Toxicokinetic / pharmacokinetic studies
- Details on excretion:
- After addition of the test item to the isolated perfused liver, about 70% of the administered dose was excreted into the bile within 3 hours. The excretion was rapid and the maximum concentration of the test item in the bile, 30-50 mg/mL, was found after about 30 minutes.
Metabolite characterisation studies
- Metabolites identified:
- not specified
- Details on metabolites:
- The concentration of the test item in the perfusion fluid decreased concomitantly with increasing biliary excretion and the recovery of the test item from perfusion fluid and bile was almost quantitative (about 95%), showing that the test item was not significantly metabolised.
Any other information on results incl. tables
The test item did not affect blood flow through the perfused liver, but the bile flow was always slightly increased during the first 30 minutes after administration.
Effect of the test item on the drug-metabolising system in the liver microsomes: The activities of N-aminopyrine demethylase and aniline hydroxylase were determined in livers taken from the perfusion experiments. There were no differences between the enzyme activities of microsomes from control and treated livers.
Experiment | No. of animals | Duration (hours) | Recovery (% of administered dose) | Total recovery (%) | |
Bile | Blood (perfusion fluid) | ||||
Perfused isolated liver | 6 | 3 | 67 ± 6 | 26 ± 4 | 93 ± 3 |
Applicant's summary and conclusion
- Conclusions:
- After addition of the test item to the isolated perfused liver, about 70% of the administered dose was excreted into the bile within 3 hours. The excretion was rapid and the maximum concentration of the test item in the bile, 30-50 mg/mL, was found after about 30 minutes. The recovery of the test item from perfusion fluid and bile was almost quantitative (about 95%), showing that the test item was not significantly metabolised.
- Executive summary:
6 anaesthetized rats were used for studying biliary excretion in an isolated perfused liver system. The test item was added to the perfusion fluid. Bile and perfusion fluid were sampled at regular intervals during the experiment. The perfusion usually lasted 3 hours. After addition of the test item to the isolated perfused liver, about 70% of the administered dose was excreted into the bile within 3 hours. The excretion was rapid and the maximum concentration of the test item in the bile was found after about 30 minutes. The recovery of the test item from perfusion fluid and bile was almost quantitative (about 95%), showing that the test item was not significantly metabolised.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.